MONTREAL, CANADA -- (MARKET WIRE) -- April 24, 2007 -- ART Advanced Research Technologies Inc. ("ART") (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced today that on Wednesday, April 25th, 2007, Sebastien Gignac, ART's President and CEO, will present an update on the Company's recent developments in achieving key milestones at the BioFinance investor conference to be held at the Toronto Marriott Eaton Centre Hotel, located at 525 Bay Street in Toronto, Canada. Mr. Gignac's presentation will take place at 10:00 a.m. (EST) in the Trinity IV room.
